publication venue for
- Selective laser sintering 3D printing - an overview of the technology and pharmaceutical applications.. 46:869-877. 2020
- Application of salt engineering to reduce/mask bitter taste of clindamycin.. 45:1871-1878. 2019
- Application of NIR chemometric methods for quantification of the crystalline fraction of warfarin sodium in drug product.. 42:584-594. 2016
- To investigate the influence of machine operating variables on formulations derived from lactose types in capsule filling: part 2.. 42:624-635. 2016
- Characterization and selection of suitable grades of lactose as functional fillers for capsule filling: part 1.. 41:1452-1463. 2015
- Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.. 41:1156-1164. 2015
- Application of chemometric methods to differential scanning calorimeter (DSC) to estimate nimodipine polymorphs from cosolvent system.. 41:995-999. 2015
- An index for evaluating difficulty of Chewing Index for chewable tablets.. 41:239-243. 2015
- Comparative evaluation of in vitro efficacy of colesevelam hydrochloride tablets.. 40:1173-1179. 2014
- Development of meloxicam in situ implant formulation by quality by design principle.. 40:66-73. 2014
- Complexation between risperidone and amberlite resin by various methods of preparation and binding study.. 35:1409-1418. 2009
- Complexation between risperidone and amberlite resin by various methods of preparation and binding study. 090526005142032-090526005142019. 2009
- Development and evaluation of a pH-dependent sustained release tablet for irritable bowel syndrome.. 35:57-64. 2009
- The influence of formulation on the dissolution profile of diclofenac sodium tablets.. 32:1103-1109. 2006
- Biodegradable microparticulates of beta-estradiol: preparation and in vitro characterization.. 31:803-811. 2005
- Bioavailability assessment of oral coenzyme Q10 formulations in dogs.. 28:1195-1200. 2002
- Formulation and stability evaluation of ketoprofen sustained-release tablets prepared by fluid bed granulation with Carbopol 971P solution.. 28:1231-1240. 2002
- Nanoparticle technology for drug delivery across the blood-brain barrier.. 28:1-13. 2002
- Preparation and characterization of coenzyme Q10-Eudragit solid dispersion.. 28:49-57. 2002
- Intraocular pressure-lowering activity and in vivo disposition of dipivalyl terbutalone in rabbits.. 27:137-141. 2001
- Biodistribution of liposomes of terbutaline sulfate in guinea pigs.. 26:1099-1105. 2000
- Preparation and pharmacodynamic evaluation of liposomes of indomethacin.. 26:313-321. 2000
- Cataplasm-based controlled drug delivery: development and optimization of a novel formulation.. 25:659-665. 1999
- Effect of menthol on permeability of an optically active and racemic propranolol across guinea pig skin.. 24:875-878. 1998
- Atenolol Gastrointestinal Therapeutic System. I. Screening of Formulation Variables. 23:157-165. 1997
- Ibuprofen Release from Beads Coated with an Experimental Latex: Effect of Certain Variables. 23:145-155. 1997
- Effect of Additives on the Diffusion of Ketoprofen Through Human Skin. 22:471-474. 1996
- Statistical Optimization of Ketoprofen-Eudragit S100 Coprecipitates to Obtain Controlled-Release Tablets. 22:135-141. 1996
- Compression of Indomethacin Coprecipitates with Polymer Mixtures: Effect of Preparation Methodology. 21:1473-1483. 1995